3785 |
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY Q MEMBER 2 |
KCNQ2 |
BFNC |
EBN |
EBN1 |
ENB1 |
HNSPC |
KCNA11 |
KV7.2 |
602235 |
6296 |
ENSG00000075043 |
OTTHUMG00000033049 |
O43526 |
Neuroblastoma-specific potassium channel subunit alpha KvLQT2 |
KQT-like 2 |
Voltage-gated potassium channel subunit Kv7.2 |
Potassium voltage-gated channel subfamily KQT member 2 |
KCNQ2_HUMAN |
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY KQT MEMBER 2 (VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT KV7.2) (NEUROBLASTOMA-SPECIFIC POTASSIUM CHANNEL ALPHA SUBUNIT KVLQT2) (KQT-LIKE 2). [SOURCE:UNIPROT/SWISSPROT;ACC:O43526] |
PA30074 |
Voltage-gated potassium channel Kv7.2 |
T74483 |
DEE7 |
Human Readable Name | DRUGGABLE GENOME |
Initial Gene Query | Kv7.2 |
Counted Citations from 1950-2000 | 344 |
Interpro Type | Domain |
Interpro Name | Ion transport domain |
Uniprot Evidence | 1: Evidence at protein level |
Human Readable Name | ION CHANNEL |
Uniprot Status | Swiss-Prot |
Interpro Acc | IPR005821 |
Interpro Short Name | Ion_trans_dom |
Target Class | Transporters |
Target Subclass | TC:1.A.1.15.2 |
Gene Biotype | PROTEIN_CODING |
ION CHANNEL |
DRUGGABLE GENOME |
activator (activating) |
blocker (inhibitory) |
Trial Name | retigabine, ezogabine,Potiga |
Novel drug target | Established target |
Mechanism of Interaction | KCNQ (Kv7) potassium channel blocker |
activator (activating) |
Mechanism of Interaction | Voltage-gated potassium channel subunit Kv7.2 activator |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
KCNQ2 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
3785 | Entrez Gene ID |
Initial Gene Query | Kv7.2 |
Counted Citations from 1950-2000 | 344 |
ION CHANNEL |
ENSG00000075043 | Ensembl Gene Id |
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY KQT MEMBER 2 (VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT KV7.2) (NEUROBLASTOMA-SPECIFIC POTASSIUM CHANNEL ALPHA SUBUNIT KVLQT2) (KQT-LIKE 2). [SOURCE:UNIPROT/SWISSPROT;ACC:O43526] | Description |
KCNQ2 | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
KCNQ2 | Gene Symbol |
Target Class | Transporters |
Target Subclass | TC:1.A.1.15.2 |
3785 | Entrez Gene Id |
KCNQ2 | Uniprot Gene Name |
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY KQT MEMBER 2 | Uniprot Protein Name |
Interpro Name | Ion transport domain |
Uniprot Evidence | 1: Evidence at protein level |
Human Readable Name | ION CHANNEL |
ION CHANNEL, DRUGGABLE GENOME |
PA30074 | PharmGKB ID |
KCNQ2 | TTD Gene Abbreviation |
T74483 | TTD Target ID |
KCNQ2 | GENE_SYMBOL |
Potassium voltage-gated channel subfamily KQT member 2 | UNIPROT |
KQT-like 2 | UNIPROT |
ENSG00000075043 | Gene Symbol |
KCNQ2 | Ensembl Id |
DRUGGABLE GENOME |
Potassium voltage-gated channel subfamily KQT member 2 | Gene Name |
O43526 | UniProt ID |
ION CHANNEL |